Resistance against anti-CD19 and anti-BCMA CAR T cells: Recent advances and coping strategies
Chimeric antigen receptor T (CAR T) cell therapy is a new treatment paradigm that has revolutionized the treatment of CD19-positive B cell malignancies and BCMA-positive plasma cell malignancies. The response rates are highly impressive in comparison to historical cohorts, but the responses are not...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2022-08-01
|
| Serier: | Translational Oncology |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S1936523322001188 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|